Cotrimoxazole prophylaxis versus mefloquine intermittent preventive treatment to prevent malaria in HIV-infected pregnant women: two randomized controlled trials.

@article{DenoeudNdam2014CotrimoxazolePV,
  title={Cotrimoxazole prophylaxis versus mefloquine intermittent preventive treatment to prevent malaria in HIV-infected pregnant women: two randomized controlled trials.},
  author={Lise Denoeud-Ndam and D Zannou and Camille Fourcade and Cl{\'e}ment Taron-Brocard and Rapha{\"e}l Porcher and Felix A Atadokp{\'e}d{\'e} and Didier Gounou Komongui and Lucien Dossou-Gb{\'e}t{\'e} and Aldric Afangnihoun and Nicaise G Tuikue Ndam and P O Girard and Michel Cot},
  journal={Journal of acquired immune deficiency syndromes},
  year={2014},
  volume={65 2},
  pages={198-206}
}
BACKGROUND Malaria during pregnancy has serious consequences that are worsened by HIV infection. Malaria preventive measures for HIV-infected pregnant women include cotrimoxazole (CTX) prophylaxis given to prevent HIV-related opportunistic infections and also protective against malaria, or intermittent preventive treatment (IPTp) with an antimalarial drug. Here, we present the first study evaluating CTX efficacy versus mefloquine (MQ)-IPTp, alone and in combination, in HIV-infected pregnant… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

Malaria during Pregnancy.

Cold Spring Harbor perspectives in medicine • 2017
View 1 Excerpt

Similar Papers

Loading similar papers…